Role of NF-kappaB2-p100 in regulatory T cell homeostasis and activation.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 09 2019
Historique:
received: 04 06 2019
accepted: 10 09 2019
entrez: 27 9 2019
pubmed: 27 9 2019
medline: 3 11 2020
Statut: epublish

Résumé

The immunological roles of the nuclear factor-kappaB (NF-κB) pathway are mediated via the canonical components in immune responses and via non-canonical components in immune organogenesis and homeostasis, although the two components are capable of crosstalk. Regulatory CD4 T cells (Tregs) are homeostatically functional and represent an interesting potential meeting point of these two NF-κB components. We show that mice deficient in the non-canonical NF-κB component gene Nfkb2 (p100) had normal thymic development and suppressive function of Tregs. However, they had enhanced frequencies of peripheral 'effector-phenotype' Tregs (eTregs). In bi-parental chimeras of wild-type (WT) and Nfkb2-/- mice, the Nfkb2-/- genotype was over-represented in Tregs, with a further increase in the relative prominence of eTregs. Consistent with distinct properties of eTregs, the Nfkb2-/- genotype was more prominent in Tregs in extra-lymphoid tissues such as liver in the bi-parental chimeras. The Nfkb2-/- Tregs also displayed greater survival, activation and proliferation in vivo. These Nfkb2-/- Tregs showed higher nuclear NF-κB activity mainly comprising of RelB-containing dimers, in contrast to the prominence of cRel- and RelA-containing dimers in WT Tregs. Since p100 is an inhibitor of RelB activation as well as a participant as cleaved p52 in RelB nuclear activity, we tested bi-parental chimeras of WT and Relb-/- mice, and found normal frequencies of Relb-/- Tregs and eTregs in these chimeric mice. Our findings confirm and extend recent data, and indicate that p100 normally restrains RelB-mediated Treg activation, and in the absence of p100, p50-RelB dimers can contribute to Treg activation.

Identifiants

pubmed: 31554891
doi: 10.1038/s41598-019-50454-z
pii: 10.1038/s41598-019-50454-z
pmc: PMC6761191
doi:

Substances chimiques

NF-kappa B p52 Subunit 0
Nfkb2 protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13867

Références

J Biol Chem. 2003 Jun 27;278(26):23278-84
pubmed: 12709443
Clin Exp Immunol. 2016 Sep;185(3):281-91
pubmed: 27124481
Immunity. 2009 May;30(5):626-35
pubmed: 19464985
Immunology. 2006 Jun;118(2):240-9
pubmed: 16771859
Annu Rev Immunol. 2009;27:693-733
pubmed: 19302050
Immunity. 2008 Mar;28(3):402-13
pubmed: 18328743
J Exp Med. 2012 Sep 24;209(10):1723-42, S1
pubmed: 22966001
J Immunol. 2007 Jun 15;178(12):7767-78
pubmed: 17548614
Cell Rep. 2014 Dec 24;9(6):2098-111
pubmed: 25497099
Nat Rev Immunol. 2014 Mar;14(3):154-65
pubmed: 24481337
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
J Immunol. 2013 Jan 15;190(2):549-55
pubmed: 23248260
J Exp Med. 2009 Dec 21;206(13):3001-14
pubmed: 19995950
J Exp Med. 2007 Jun 11;204(6):1257-65
pubmed: 17502665
Science. 2003 Feb 14;299(5609):1057-61
pubmed: 12522256
J Exp Med. 2014 Jan 13;211(1):121-36
pubmed: 24378538
Oncogene. 2016 Jun 16;35(24):3083-91
pubmed: 26500059
Immunity. 2017 Sep 19;47(3):450-465.e5
pubmed: 28889947
Nucleic Acids Res. 2018 Jul 2;46(W1):W537-W544
pubmed: 29790989
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W193-200
pubmed: 17478515
Cell. 2017 Sep 7;170(6):1096-1108.e13
pubmed: 28886380
J Immunol. 2018 Feb 15;200(4):1325-1334
pubmed: 29298831
PLoS One. 2012;7(3):e34547
pubmed: 22479644
J Exp Med. 2011 Jun 6;208(6):1279-89
pubmed: 21606508
Genome Biol. 2014;15(12):550
pubmed: 25516281
Blood. 2007 Jan 1;109(1):194-202
pubmed: 16968902
J Immunol. 2013 May 15;190(10):5057-64
pubmed: 23576681
Cell Rep. 2017 Sep 19;20(12):2906-2920
pubmed: 28889989
J Immunol. 2007 Jan 1;178(1):301-11
pubmed: 17182567
J Exp Med. 2007 Jun 11;204(6):1335-47
pubmed: 17548521
Cell Death Differ. 2018 Jan;25(1):65-80
pubmed: 29149100
J Exp Med. 1998 Jan 19;187(2):185-96
pubmed: 9432976
Nat Immunol. 2014 Jan;15(1):15-25
pubmed: 24352326
J Immunol. 2010 Sep 15;185(6):3295-304
pubmed: 20720211
Nat Protoc. 2007;2(7):1789-94
pubmed: 17641646
Immunity. 2008 Jan;28(1):100-11
pubmed: 18199417
J Exp Med. 2000 Jul 17;192(2):295-302
pubmed: 10899916
Elife. 2015 Apr 23;4:
pubmed: 25905673
J Exp Med. 2003 Sep 1;198(5):737-46
pubmed: 12939344
Immunity. 2003 Sep;19(3):377-89
pubmed: 14499113
Oncogene. 2001 Nov 22;20(53):7722-33
pubmed: 11753650
FASEB J. 2015 Feb;29(2):443-54
pubmed: 25376833
Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):15946-51
pubmed: 25349408
Nat Immunol. 2014 Nov;15(11):1070-8
pubmed: 25263123
Front Immunol. 2019 May 07;10:997
pubmed: 31134075
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
J Clin Invest. 2013 Feb;123(2):580-93
pubmed: 23281398
Curr Mol Med. 2011 Nov;11(8):633-49
pubmed: 21902653
Immunity. 2014 Nov 20;41(5):722-36
pubmed: 25464853
Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9619-24
pubmed: 19487661
Cancer Immunol Res. 2013 Nov;1(5):320-31
pubmed: 24416730
Int Immunol. 2008 Mar;20(3):307-15
pubmed: 18184698
Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761
pubmed: 29155950
J Immunol. 1996 Nov 1;157(9):3974-9
pubmed: 8892630
Nat Immunol. 2002 Feb;3(2):135-42
pubmed: 11812990
J Clin Invest. 2006 Nov;116(11):2964-71
pubmed: 17039258
J Immunol. 2005 Feb 15;174(4):1783-6
pubmed: 15699103
Int J Clin Exp Pathol. 2013;6(2):116-23
pubmed: 23329997
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3503-8
pubmed: 18292232
J Immunol. 2008 Jan 15;180(2):774-82
pubmed: 18178815
Eur J Immunol. 2019 Mar;49(3):398-412
pubmed: 30620397
Nucleic Acids Res. 2018 Jan 4;46(D1):D649-D655
pubmed: 29145629
J Immunol. 1995 Aug 1;155(3):1151-64
pubmed: 7636184
J Immunol. 2007 Feb 1;178(3):1433-42
pubmed: 17237391
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Mediators Inflamm. 2016;2016:7132158
pubmed: 27239104
PLoS One. 2013 Sep 20;8(9):e76216
pubmed: 24073289
J Autoimmun. 2016 Jun;70:52-62
pubmed: 27068879
Front Immunol. 2018 Dec 18;9:2969
pubmed: 30619326
Nat Immunol. 2006 Jul;7(7):763-72
pubmed: 16732290
Nat Rev Immunol. 2017 Sep;17(9):545-558
pubmed: 28580957
J Immunol. 2011 Sep 15;187(6):3186-97
pubmed: 21849683
Nat Immunol. 2011 Apr;12(4):304-11
pubmed: 21378976
Nat Commun. 2015 Sep 14;6:8266
pubmed: 26365427
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13031-6
pubmed: 12242333
Dev Biol. 2010 Jun 15;342(2):146-56
pubmed: 20347762
J Immunol. 2002 Sep 1;169(5):2461-5
pubmed: 12193715
Blood. 2012 May 31;119(22):5155-63
pubmed: 22403258
J Immunol. 2018 Apr 1;200(7):2362-2371
pubmed: 29459403
Oncogene. 2017 Mar;36(10):1417-1429
pubmed: 27641334

Auteurs

Atika Dhar (A)

National Institute of Immunology, New Delhi, India.

Meenakshi Chawla (M)

National Institute of Immunology, New Delhi, India.

Somdeb Chattopadhyay (S)

National Institute of Immunology, New Delhi, India.

Neelam Oswal (N)

National Institute of Immunology, New Delhi, India.

Danish Umar (D)

National Institute of Immunology, New Delhi, India.

Suman Gupta (S)

National Institute of Immunology, New Delhi, India.

Vineeta Bal (V)

National Institute of Immunology, New Delhi, India.

Satyajit Rath (S)

National Institute of Immunology, New Delhi, India. satyajit@nii.ac.in.

Anna George (A)

National Institute of Immunology, New Delhi, India.

G Aneeshkumar Arimbasseri (GA)

National Institute of Immunology, New Delhi, India.

Soumen Basak (S)

National Institute of Immunology, New Delhi, India.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH